BioCorRx (OTC:BICX) said today that it partnered with the Virtual Reality Medical Center to conduct a study on the company’s long-lasting naltrexone implant.
BioCorRx’s recovery program consists of a long-lasting implant that delivers an opioid antagonist, naltrexone, which reduces physical cravings for alcohol and opioids. The recovery service also has a counseling program specifically designed to treat alcohol and substance abuse addictions in people receiving long-term naltrexone therapy.
Get the full story at our sister site, Drug Delivery Business News.